JP2002510611A5 - - Google Patents

Download PDF

Info

Publication number
JP2002510611A5
JP2002510611A5 JP2000541974A JP2000541974A JP2002510611A5 JP 2002510611 A5 JP2002510611 A5 JP 2002510611A5 JP 2000541974 A JP2000541974 A JP 2000541974A JP 2000541974 A JP2000541974 A JP 2000541974A JP 2002510611 A5 JP2002510611 A5 JP 2002510611A5
Authority
JP
Japan
Prior art keywords
ciprofloxacin
drug
liposomes
liposome
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000541974A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002510611A (ja
Filing date
Publication date
Priority claimed from US09/054,857 external-priority patent/US5972379A/en
Application filed filed Critical
Publication of JP2002510611A publication Critical patent/JP2002510611A/ja
Publication of JP2002510611A5 publication Critical patent/JP2002510611A5/ja
Pending legal-status Critical Current

Links

JP2000541974A 1998-04-02 1999-03-24 キノロン含有リポソームおよびそれらの抗菌物質としての使用 Pending JP2002510611A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/054,857 1998-04-02
US09/054,857 US5972379A (en) 1995-02-14 1998-04-02 Liposome composition and method for administering a quinolone
PCT/US1999/006500 WO1999051202A2 (en) 1998-04-02 1999-03-24 Quinolone containing liposomes and their use as antibacterial agents

Publications (2)

Publication Number Publication Date
JP2002510611A JP2002510611A (ja) 2002-04-09
JP2002510611A5 true JP2002510611A5 (https=) 2006-04-06

Family

ID=21993954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000541974A Pending JP2002510611A (ja) 1998-04-02 1999-03-24 キノロン含有リポソームおよびそれらの抗菌物質としての使用

Country Status (16)

Country Link
US (1) US5972379A (https=)
EP (1) EP1083881B1 (https=)
JP (1) JP2002510611A (https=)
KR (1) KR100617921B1 (https=)
CN (1) CN1149978C (https=)
AT (1) ATE274342T1 (https=)
AU (1) AU763989B2 (https=)
CA (1) CA2326497A1 (https=)
DE (1) DE69919698T2 (https=)
DK (1) DK1083881T3 (https=)
ES (1) ES2226371T3 (https=)
IL (1) IL138685A0 (https=)
NZ (1) NZ506970A (https=)
PT (1) PT1083881E (https=)
WO (1) WO1999051202A2 (https=)
ZA (1) ZA200005333B (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311924B2 (en) 1999-04-01 2007-12-25 Hana Biosciences, Inc. Compositions and methods for treating cancer
US20030147944A1 (en) * 1999-12-10 2003-08-07 Mayer Lawrence D Lipid carrier compositions with protected surface reactive functions
JP2004501955A (ja) * 2000-06-30 2004-01-22 アイネックス　ファーマシューティカルズ　コーポレイション リポソーム抗新生物薬剤およびその使用
US7452550B2 (en) 2000-06-30 2008-11-18 Hana Biosciences, Inc. Liposomal antineoplastic drugs and uses thereof
EP1355634B8 (en) 2000-11-09 2009-03-04 Neopharm, Inc. Sn-38 lipid complexes and methods of use
WO2003030864A1 (en) 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
PL369455A1 (en) * 2001-06-01 2005-04-18 Yamanouchi Europe B.V. Lipid-polymer-conjugates
AU2002334358B2 (en) * 2001-09-06 2008-02-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposome formulations with a predefined release profile
US20040219201A1 (en) * 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
PT1581236E (pt) * 2002-10-29 2013-12-24 Insmed Inc Libertação prolongada de anti-infecciosos
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP1628637A2 (en) * 2003-05-30 2006-03-01 Alza Corporation Method of pulmonary administration of an agent
CN100431525C (zh) * 2003-07-17 2008-11-12 台湾东洋药品工业股份有限公司 脂质体悬浮液制造方法及含该法所制脂质体悬浮液的产物
US8173840B2 (en) * 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
US7589233B2 (en) * 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
AU2004289174B2 (en) * 2003-07-29 2011-05-19 Signature R&D Holdings, Lcc Amino acid prodrugs
US7915223B2 (en) * 2004-09-27 2011-03-29 Technion Research & Development Foundation Ltd. Antimicrobial agents
WO2006039369A1 (en) * 2004-09-29 2006-04-13 Alza Corporation Microparticles and nanoparticles containing a lipopolymer
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
CN100403535C (zh) * 2005-05-18 2008-07-16 崇贸科技股份有限公司 可控制触发电压的静电放电装置
EP3067047B1 (en) 2005-12-08 2022-04-20 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
KR100916160B1 (ko) * 2007-02-21 2009-09-08 (주)바이오버드 약제학적 항암 조성물
EP2152289A1 (en) * 2007-04-30 2010-02-17 Technion Research & Development Foundation Ltd. Novel antimicrobial agents
US20100173832A1 (en) * 2007-04-30 2010-07-08 Technion Research & Development Foundation Ltd. Anticancerous polymeric agents
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CA2781527C (en) * 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes
CN102309448B (zh) * 2010-06-29 2014-07-09 中国人民解放军军事医学科学院毒物药物研究所 一种肺部给药的环丙沙星药用组合物及其制备方法
CN102188430B (zh) * 2011-04-06 2012-08-15 广东如来医药进出口有限公司 司帕沙星化合物的组合物制剂及其制备方法
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
MX2015005992A (es) 2012-11-20 2016-03-07 Spectrum Pharmaceuticals Inc Metodo mejorado para la preparacion de la vincristina liposomal encapsulada para el uso terapeutico.
US10124066B2 (en) 2012-11-29 2018-11-13 Insmed Incorporated Stabilized vancomycin formulations
WO2015061025A1 (en) 2013-10-22 2015-04-30 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
LT3466432T (lt) 2014-05-15 2020-12-28 Insmed Incorporated Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti
EP2957561A1 (en) * 2014-06-18 2015-12-23 Université Paris 6 Pierre et Marie Curie UPMC Novel fluoroquinolones and use thereof to treat bacterial infections
TWI678213B (zh) 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
GB2552301A (en) * 2016-07-11 2018-01-24 Evox Therapeutics Ltd Metabolic drug loading of EVs
US20170172921A1 (en) * 2016-12-14 2017-06-22 Mahmoud Reza Jaafari Polyphenolic compounds encapsualated in long circulating liposomes and use thereof
TWI728255B (zh) * 2017-07-24 2021-05-21 國邑藥品科技股份有限公司 包含弱酸藥物之脂質體組成物及其用途
CN109305987B (zh) * 2017-07-27 2021-04-20 济南大学 环丙沙星金属配合物及其制备方法和应用
EP3773505B1 (en) 2018-03-30 2026-04-29 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
JP7449275B2 (ja) 2018-05-02 2024-03-13 インスメッド インコーポレイテッド リポソーム薬物製剤の製造方法
AU2019339401B9 (en) * 2018-09-14 2022-11-03 Pharmosa Biopharm Inc. Pharmaceutical composition for controlled release of weak acid drugs and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
ATE63124T1 (de) * 1986-03-14 1991-05-15 Fujisawa Pharmaceutical Co Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
US5057523A (en) * 1988-09-22 1991-10-15 Abbott Laboratories Dipeptide quinolone derivatives
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
WO1991009616A1 (en) * 1989-12-22 1991-07-11 Yale University Quinolone antibiotics encapsulated in lipid vesicles
DK0555229T3 (da) * 1990-07-31 1996-08-19 Liposome Co Inc Akkumulation af aminosyrer og peptider i liposomer
CA2101241C (en) * 1993-07-23 1998-12-22 Jonathan P. Wong Liposome-encapsulated ciprofloxacin
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5741516A (en) * 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
AU4981896A (en) * 1995-02-14 1996-09-04 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering liposome-loadable drugs
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
US5837282A (en) * 1996-10-30 1998-11-17 University Of British Columbia Ionophore-mediated liposome loading

Similar Documents

Publication Publication Date Title
JP2002510611A5 (https=)
AU763989B2 (en) Quinolone containing liposomes and their use as antibacterial agents
CN105163720A (zh) 远程装载略微水溶性药物至脂质体
JP2006515578A (ja) 勾配によるリポソームへの薬物充填方法
ES2303114T3 (es) Metodo para cargar medicamentos en liposomas.
US20030219473A1 (en) Cochleates made with purified soy phosphatidylserine
HUP0201644A2 (hu) A hatóanyag javított megtartására alkalmazható liposzómakészítmény
US9540638B2 (en) Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method
CN111388423A (zh) 一种盐酸莫西沙星脂质体的制备方法
CN113398072B (zh) 注射用头孢唑林钠及其制备方法
EP3324969B1 (en) A ready-to-use formulation for vincristine sulfate liposome injection
TWI850208B (zh) 緩釋型翠普登組成物及其經皮下或類似途徑使用之方法
KR20200056234A (ko) 경구투여용 글루타치온 함유 프로리포좀, 이를 포함하는 약제학적 조성물 및 이의 제조방법
HK1035331B (en) Liposome composition and method for administering a quinolone
Malysheva et al. Effects of local anesthetics on properties of tetrodotoxin-sensitive protein reconstituted into liposomes
CN116440079A (zh) 经鼻给药脑靶向主动载药的布美他尼脂质体
TW202033184A (zh) 含有免疫調節劑的緩釋藥物組合物及其用途
CN107837234A (zh) 一种改善药物释放的脂质体及其制备方法
JPWO2001000173A1 (ja) リポソームに内包された薬物の漏出抑制方法